Wet Age‑Related Macular Degeneration Market to Witness Robust Growth by 2035 – BIS Research

What is Wet Age‑Related Macular Degeneration (Wet AMD)? 

Wet AMD is a progressive eye condition wherein abnormal blood vessels grow under the retina, leading to leakage, rapid central vision loss, and potential blindness. It requires urgent treatment typically through anti‑VEGF injections, and emerging therapies like gene therapy and sustained‑release implants to prevent irreversible vision damage. 

What Is the Market Outlook? 

The market is undergoing transformation as demographic shifts, innovation in drug delivery, and advances in imaging technologies reshape clinical practice. Pharmaceutical companies are investing in gene therapies, extended dosing treatments, and portable diagnostic devices, while strategic mergers and regulatory approvals are enhancing access and adoption. 

How Fast Is the Market Growing? 

The market is witnessing steady growth, fueled by an emphasis on early detection, improved patient adherence, and the increasing adoption of novel biologics and imaging systems across ophthalmology clinics and specialized eye centers. 

Request sample report on Wet Age‑Related Macular Degeneration Market 

How Will This Report Help You? 

Planning to Enter the Market? 

Gain regional insights and assess unmet needs across different patient populations and healthcare settings. 

Analyzing the Competitive Landscape? 

Identify key players, track innovation pipelines, and benchmark commercial strategies involving novel therapies and delivery systems. 

Seeking R&D Insights? 

Explore breakthroughs in gene therapy, implantable drug devices, and non-invasive imaging tools to guide your development roadmap. 

Interested in Regional Trends? 

Understand the adoption rate of therapies, regulatory landscape, and healthcare access across developed and emerging economies. 

Download the Full TOC and Report Sample     

What Technologies Are Transforming the Market? 

• Novel anti‑VEGF biologics with extended dosing 
• Sustained‑release implants and port delivery systems 
• Gene therapy platforms for long-term disease control 
• AI-powered OCT and fundus imaging tools 
• Remote ophthalmology diagnostics and mobile screening units 

Unlock Critical Insights with Surgical Procedure Database  

Discover BIS Research Surgical Procedure Volume Database – your key to real-world, country-level procedural insights across MedTech.   

What’s Driving Demand, Opportunity, and Barriers?

Drivers 

• Growing elderly population worldwide 
• Increasing prevalence of vision-threatening eye disorders 
• Advances in biologics and delivery mechanisms 

Restraints 

• High cost of care and biologic therapies 
• Treatment fatigue due to frequent injections 
• Limited ophthalmology infrastructure in rural areas 

Opportunities 

• Gene therapy adoption for extended disease control 
• Expansion of mobile eye care and teleophthalmology 
• Partnerships for awareness and early diagnosis programs 

How Is the Market Segmented? 

by Treatment Type 

•    Anti-VEGF Therapies 

•    Gene Therapy 

•    Others 

by Region 

•    North America 

•    Europe  

•    Asia-Pacific 

Strategic Moves Shaping the Future: 

• Strategic acquisitions to build ophthalmic pipelines 
• Regulatory fast-tracking of novel treatments 
• Cross-border partnerships to expand access in emerging markets 
• Investments in AI-guided screening and diagnostics 

Download the complete TOC now! 

Case Study 

Merck’s acquisition of Eyebiotech (EyeBio) for its mid-stage Wet AMD drug Restoret highlights how major pharmaceutical firms are aggressively expanding into the ophthalmology segment. The deal underscores growing confidence in the commercial viability of advanced macular degeneration therapies and their role in addressing unmet patient needs. 

Schedule a Call with Industry Experts  

Related Reports from BIS Research  

Gene Fusion Testing Market 

Global Cell and Gene Therapy Market 

Global Stem Cell Therapy Market 

About BIS Research  

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.    

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.     

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.    

Contact  

Head of Marketing   

Email: media@bisresearch.com     

BIS Research Inc.    

39111 PASEO PADRE PKWY STE 313,    

FREMONT, CA 94538-1686   

Visit our Blog @https://bisresearch.com/insights    

Get Expert Insights @https://community.insightmonk.com     

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research     

Connect with us on Twitter@ https://twitter.com/BISResearch    

Connect with us on Medium@ https://medium.com/@faisal.bis  

Connect with us on youtube@ https://www.youtube.com/@BISResearchInc